Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (141-150 of 285) with videos related to

Pageof 29
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphoniumIgal Madar, Yi Huang, Hayden Ravert, et al.
Breast Cancer Research : BCR|September 22, 2016
WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell linesMatthew J Sikora, Britta M Jacobsen, Kevin Levine, et al.
Meta Gene|May 26, 2015
Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugsScooter Willis, Pradip De, Nandini Dey, et al.
British Journal of Cancer|December 2, 2015
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)Bryan P Schneider, Anne O'Neill, Fei Shen, et al.
Breast Cancer Research and Treatment|March 25, 2010
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198Antonio C Wolff, Molin Wang, Hailun Li, et al.
Clinical Breast Cancer|November 10, 2005
Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193Antonio C Wolff, Anne O'Neill, M John Kennedy, et al.
Cancer Investigation|November 23, 2006
A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology GroupRobert W Carlson, Anne M O'Neill, Lori J Goldstein, et al.
Journal of Physical Activity & Health|December 1, 2025
Comparisons of Physical Activity and Sedentary Behavior Measurements From the ActiGraph, International Physical Activity Questionnaire, and Fitbit in Women With History of Breast CancerEileen Rillamas-Sun, Yuhan Huang, Blake O Langley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancerAntonio C Wolff, Deborah K Armstrong, John H Fetting, et al.
The Journal of Biological Chemistry|March 10, 2005
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancerAgoston T Agoston, Pedram Argani, Srinivasan Yegnasubramanian, et al.
Pageof 29

Showing results (141-150 of 285) with videos related to

Sort By:
Pageof 29
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphoniumIgal Madar, Yi Huang, Hayden Ravert, et al.
Breast Cancer Research : BCR|September 22, 2016
WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell linesMatthew J Sikora, Britta M Jacobsen, Kevin Levine, et al.
Meta Gene|May 26, 2015
Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugsScooter Willis, Pradip De, Nandini Dey, et al.
British Journal of Cancer|December 2, 2015
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)Bryan P Schneider, Anne O'Neill, Fei Shen, et al.
Breast Cancer Research and Treatment|March 25, 2010
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198Antonio C Wolff, Molin Wang, Hailun Li, et al.
Clinical Breast Cancer|November 10, 2005
Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193Antonio C Wolff, Anne O'Neill, M John Kennedy, et al.
Cancer Investigation|November 23, 2006
A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology GroupRobert W Carlson, Anne M O'Neill, Lori J Goldstein, et al.
Journal of Physical Activity & Health|December 1, 2025
Comparisons of Physical Activity and Sedentary Behavior Measurements From the ActiGraph, International Physical Activity Questionnaire, and Fitbit in Women With History of Breast CancerEileen Rillamas-Sun, Yuhan Huang, Blake O Langley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancerAntonio C Wolff, Deborah K Armstrong, John H Fetting, et al.
The Journal of Biological Chemistry|March 10, 2005
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancerAgoston T Agoston, Pedram Argani, Srinivasan Yegnasubramanian, et al.
Pageof 29